Search research articles
Contact Us
Filters
Showing results (251-260 of 266) with videos related to
Page
of 27
Sort By:
Brain : a Journal of Neurology
|
October 21, 2017
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
Tomas Kalincik, Ali Manouchehrinia, Lukas Sobisek, et al.
Neurology
|
October 6, 2021
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Steve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 26, 2023
Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand
Julien Coussement, Christopher H Heath, Matthew B Roberts, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 5, 2016
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Chunrong Tao, Steve Simpson, Ingrid van der Mei, et al.
The Lancet. Neurology
|
February 18, 2017
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
Tomas Kalincik, J William L Brown, Neil Robertson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2024
Management, Outcomes, and Predictors of Mortality of Cryptococcus Infection in Patients Without HIV: A Multicenter Study in 46 Hospitals in Australia and New Zealand
Julien Coussement, Christopher H Heath, Matthew B Roberts, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 29, 2022
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiative
Liesbet M Peeters, Tina Parciak, Clare Walton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 9, 2016
Contribution of different relapse phenotypes to disability in multiple sclerosis
Tamasine Stewart, Tim Spelman, Eva Havrdova, et al.
Frontiers in Neurology
|
January 8, 2024
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Tim Spelman, Melinda Magyari, Helmut Butzkueven, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 266) with videos related to
Sort By:
Page
of 27
Brain : a Journal of Neurology
|
October 21, 2017
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
Tomas Kalincik, Ali Manouchehrinia, Lukas Sobisek, et al.
Neurology
|
October 6, 2021
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Steve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 26, 2023
Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand
Julien Coussement, Christopher H Heath, Matthew B Roberts, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 5, 2016
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Chunrong Tao, Steve Simpson, Ingrid van der Mei, et al.
The Lancet. Neurology
|
February 18, 2017
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
Tomas Kalincik, J William L Brown, Neil Robertson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2024
Management, Outcomes, and Predictors of Mortality of Cryptococcus Infection in Patients Without HIV: A Multicenter Study in 46 Hospitals in Australia and New Zealand
Julien Coussement, Christopher H Heath, Matthew B Roberts, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 29, 2022
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiative
Liesbet M Peeters, Tina Parciak, Clare Walton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 9, 2016
Contribution of different relapse phenotypes to disability in multiple sclerosis
Tamasine Stewart, Tim Spelman, Eva Havrdova, et al.
Frontiers in Neurology
|
January 8, 2024
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Tim Spelman, Melinda Magyari, Helmut Butzkueven, et al.
Page
of 27